Villaganas, Ellaine B.
HRN: 27-41-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/01/2025
07/08/2025
IV
500 Mg
Q 6 Hours
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: